Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Mariel Metcalfe
  • October 20, 2017
  • News

Research Partnership launches new patient Living with Psoriasis 2017 (EU) report

Research Partnership launches new patient Living with Psoriasis 2017 (EU) report

Living with Psoriasis is a study conducted amongst 615 patients in Europe. The report will consist of 30-minute online interviews with 600 patients and 15 qualitative interviews. It can be purchased as either a 5EU report (sample of 500 patients) or as a 7EU report (sample of 600 patients with the additional countries of Belgium and the Netherlands).  It will be available to purchase in December 2017.

read more »

  • Posted by Tom Nolte
  • October 11, 2017
  • Webinars

Live webinar: Portfolio analysis - Choosing your communication strategy

Live webinar: Portfolio analysis - Choosing your communication strategy

Thursday 16th November 2017 11:00 EDT / 16:00 GMT / 17:00 CEST

Portfolio Analysis and Optimization concentrates on determining the impact that multiple assets within therapeutic categories, and the marketing of these assets, has on overall strategy. This is an important tool for pharmaceutical companies in today’s market. As they simultaneously develop multiple products that can cost millions of dollars, portfolio management to improve decision-making can have a significant impact on the bottom line. At its very core, it is about selecting how to allocate resources and marketing efforts across multiple assets.
 
 

read more »

  • Posted by Rachel Howard
  • October 6, 2017
  • Articles

Deep Dive - MINT: opportunities in ‘frontier’ markets?

Deep Dive - MINT: opportunities in ‘frontier’ markets?

Published in Pharmaphorum’s Deep Dive magazine October 2017

According to British economist Jim O’Neill, MINT is the new BRIC. What is MINT? An acronym he coined for the ‘frontier’ markets of Mexico, Indonesia, Nigeria and Turkey. These are the countries he believes are poised for strong economic growth, like the emerging markets of BRIC (Brazil, Russia, India and China) before them. What are the prospects for pharma in MINT? Research Partnership’s Rachel Howard and Sue Rees investigate the pros and cons.

read more »

  • Posted by Marc Yates
  • October 3, 2017
  • Webinars

Webcast: Going for growth - Maximising your return on insights in Emerging Markets

Webcast: Going for growth - Maximising your return on insights in Emerging Markets

Healthcare market research in emerging markets is still evolving, so finding the insights you require and then maximising the return on those insights can be challenging. Download this complimentary webcast in which Emerging Markets Directors Marc Yates and Rachel Howard will provide you with the critical success factors to ensure actionable primary research in emerging markets.

read more »

  • Posted by Julie Denny
  • September 28, 2017
  • Videos

20 questions: Round 6

As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month we asked our employees about office life in Singapore.

read more »